| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hyalurononglucosaminidase activity | 1.64e-07 | 9 | 26 | 3 | GO:0004415 | |
| GeneOntologyMolecularFunction | hexosaminidase activity | 1.32e-06 | 17 | 26 | 3 | GO:0015929 | |
| GeneOntologyMolecularFunction | hyaluronoglucuronidase activity | 1.63e-06 | 2 | 26 | 2 | GO:0033906 | |
| GeneOntologyMolecularFunction | virus receptor activity | 1.80e-04 | 85 | 26 | 3 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 1.87e-04 | 86 | 26 | 3 | GO:0140272 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 3.18e-04 | 103 | 26 | 3 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 8.46e-04 | 144 | 26 | 3 | GO:0016798 | |
| GeneOntologyBiologicalProcess | cellular response to UV-B | 3.88e-07 | 12 | 26 | 3 | GO:0071493 | |
| GeneOntologyBiologicalProcess | hyaluronan catabolic process | 1.43e-06 | 18 | 26 | 3 | GO:0030214 | |
| GeneOntologyBiologicalProcess | response to UV-B | 2.33e-06 | 21 | 26 | 3 | GO:0010224 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan catabolic process | 8.61e-06 | 32 | 26 | 3 | GO:0006027 | |
| GeneOntologyBiologicalProcess | aminoglycan catabolic process | 1.46e-05 | 38 | 26 | 3 | GO:0006026 | |
| GeneOntologyBiologicalProcess | hyaluronan metabolic process | 1.70e-05 | 40 | 26 | 3 | GO:0030212 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-1 | 1.64e-04 | 85 | 26 | 3 | GO:0071347 | |
| GeneOntologyBiologicalProcess | cellular response to UV | 2.42e-04 | 97 | 26 | 3 | GO:0034644 | |
| GeneOntologyBiologicalProcess | mucopolysaccharide metabolic process | 2.65e-04 | 100 | 26 | 3 | GO:1903510 | |
| GeneOntologyBiologicalProcess | response to interleukin-1 | 3.70e-04 | 112 | 26 | 3 | GO:0070555 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan metabolic process | 4.64e-04 | 121 | 26 | 3 | GO:0030203 | |
| GeneOntologyBiologicalProcess | cellular response to light stimulus | 5.72e-04 | 130 | 26 | 3 | GO:0071482 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 5.97e-04 | 313 | 26 | 4 | GO:0098742 | |
| GeneOntologyBiologicalProcess | aminoglycan metabolic process | 5.98e-04 | 132 | 26 | 3 | GO:0006022 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative catabolic process | 6.72e-04 | 323 | 26 | 4 | GO:1901136 | |
| MousePheno | increased hyaluronic acid level | 1.84e-05 | 6 | 16 | 2 | MP:0014429 | |
| MousePheno | abnormal hyaluronic acid level | 4.40e-05 | 9 | 16 | 2 | MP:0014426 | |
| MousePheno | cleft palate | 2.68e-04 | 289 | 16 | 4 | MP:0000111 | |
| MousePheno | oral cleft | 2.75e-04 | 291 | 16 | 4 | MP:0021164 | |
| MousePheno | abnormal glycosaminoglycan level | 3.06e-04 | 23 | 16 | 2 | MP:0011475 | |
| MousePheno | abnormal telencephalon development | 3.67e-04 | 126 | 16 | 3 | MP:0000934 | |
| MousePheno | abnormal palate morphology | 3.99e-04 | 321 | 16 | 4 | MP:0003755 | |
| Domain | Hyaluronidase | 2.11e-08 | 5 | 25 | 3 | IPR018155 | |
| Domain | Glyco_hydro_56 | 2.11e-08 | 5 | 25 | 3 | PF01630 | |
| Domain | EGF | 1.31e-05 | 235 | 25 | 5 | SM00181 | |
| Domain | EGF-like_dom | 1.73e-05 | 249 | 25 | 5 | IPR000742 | |
| Domain | - | 2.35e-05 | 42 | 25 | 3 | 3.20.20.70 | |
| Domain | Aldolase_TIM | 2.71e-05 | 44 | 25 | 3 | IPR013785 | |
| Domain | Desmosomal_cadherin | 3.60e-05 | 7 | 25 | 2 | IPR009122 | |
| Domain | Cadherin_pro | 3.60e-05 | 7 | 25 | 2 | PF08758 | |
| Domain | Glycoside_hydrolase_SF | 4.75e-05 | 53 | 25 | 3 | IPR017853 | |
| Domain | Cadherin_pro_dom | 4.79e-05 | 8 | 25 | 2 | IPR014868 | |
| Domain | Cadherin_pro | 4.79e-05 | 8 | 25 | 2 | SM01055 | |
| Domain | - | 2.21e-04 | 679 | 25 | 6 | 3.30.160.60 | |
| Domain | zf-C2H2 | 2.47e-04 | 693 | 25 | 6 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 2.49e-04 | 694 | 25 | 6 | IPR013087 | |
| Domain | EGF_3 | 2.51e-04 | 235 | 25 | 4 | PS50026 | |
| Domain | EGF_1 | 3.43e-04 | 255 | 25 | 4 | PS00022 | |
| Domain | EGF-like_CS | 3.74e-04 | 261 | 25 | 4 | IPR013032 | |
| Domain | EGF_2 | 3.96e-04 | 265 | 25 | 4 | PS01186 | |
| Domain | Cadherin_CS | 4.05e-04 | 109 | 25 | 3 | IPR020894 | |
| Domain | Cadherin | 4.50e-04 | 113 | 25 | 3 | PF00028 | |
| Domain | CADHERIN_1 | 4.50e-04 | 113 | 25 | 3 | PS00232 | |
| Domain | ZINC_FINGER_C2H2_2 | 4.50e-04 | 775 | 25 | 6 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 4.57e-04 | 777 | 25 | 6 | PS00028 | |
| Domain | CADHERIN_2 | 4.62e-04 | 114 | 25 | 3 | PS50268 | |
| Domain | - | 4.62e-04 | 114 | 25 | 3 | 2.60.40.60 | |
| Domain | CA | 4.74e-04 | 115 | 25 | 3 | SM00112 | |
| Domain | Cadherin-like | 4.86e-04 | 116 | 25 | 3 | IPR015919 | |
| Domain | Cadherin_C | 5.06e-04 | 25 | 25 | 2 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 5.06e-04 | 25 | 25 | 2 | IPR000233 | |
| Domain | Cadherin | 5.11e-04 | 118 | 25 | 3 | IPR002126 | |
| Domain | Znf_C2H2-like | 5.19e-04 | 796 | 25 | 6 | IPR015880 | |
| Domain | Znf_C2H2 | 5.51e-04 | 805 | 25 | 6 | IPR007087 | |
| Domain | ZnF_C2H2 | 5.62e-04 | 808 | 25 | 6 | SM00355 | |
| Domain | Catenin_binding_dom | 6.83e-04 | 29 | 25 | 2 | IPR027397 | |
| Domain | FYVE | 6.83e-04 | 29 | 25 | 2 | PF01363 | |
| Domain | FYVE | 6.83e-04 | 29 | 25 | 2 | SM00064 | |
| Domain | - | 6.83e-04 | 29 | 25 | 2 | 4.10.900.10 | |
| Domain | Znf_FYVE-rel | 9.40e-04 | 34 | 25 | 2 | IPR017455 | |
| Domain | Znf_FYVE | 1.17e-03 | 38 | 25 | 2 | IPR000306 | |
| Domain | ZF_FYVE | 1.30e-03 | 40 | 25 | 2 | PS50178 | |
| Domain | SCAN | 2.53e-03 | 56 | 25 | 2 | SM00431 | |
| Domain | SCAN_BOX | 2.72e-03 | 58 | 25 | 2 | PS50804 | |
| Domain | SCAN | 2.72e-03 | 58 | 25 | 2 | PF02023 | |
| Domain | SCAN_dom | 2.72e-03 | 58 | 25 | 2 | IPR003309 | |
| Domain | Retrov_capsid_C | 2.81e-03 | 59 | 25 | 2 | IPR008916 | |
| Domain | ConA-like_dom | 3.02e-03 | 219 | 25 | 3 | IPR013320 | |
| Domain | - | 7.12e-03 | 95 | 25 | 2 | 2.60.120.200 | |
| Domain | zf-C2H2_6 | 8.23e-03 | 314 | 25 | 3 | PF13912 | |
| Domain | Znf_FYVE_PHD | 1.64e-02 | 147 | 25 | 2 | IPR011011 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DERMATAN_SULFATE_DEGRADATION | 9.75e-08 | 8 | 18 | 3 | M47607 | |
| Pathway | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | 3.82e-07 | 12 | 18 | 3 | M660 | |
| Pathway | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | 3.82e-07 | 12 | 18 | 3 | MM14868 | |
| Pathway | REACTOME_HYALURONAN_METABOLISM | 1.18e-06 | 17 | 18 | 3 | M666 | |
| Pathway | REACTOME_HYALURONAN_METABOLISM | 1.18e-06 | 17 | 18 | 3 | MM14864 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_DEGRADATION | 2.29e-06 | 21 | 18 | 3 | M3624 | |
| Pathway | REACTOME_CS_DS_DEGRADATION | 1.19e-04 | 13 | 18 | 2 | MM14805 | |
| Pathway | REACTOME_CS_DS_DEGRADATION | 1.39e-04 | 14 | 18 | 2 | M651 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_DEGRADATION | 2.07e-04 | 17 | 18 | 2 | M39832 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 4.81e-04 | 123 | 18 | 3 | MM14623 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 5.16e-04 | 126 | 18 | 3 | M695 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 1.68e-03 | 48 | 18 | 2 | MM14696 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 1.82e-03 | 50 | 18 | 2 | M678 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 4.63e-03 | 271 | 18 | 3 | MM15406 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 5.40e-03 | 87 | 18 | 2 | MM15351 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 5.49e-03 | 288 | 18 | 3 | M16864 | |
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 21699545 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 18653706 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 31758257 | ||
| Pubmed | Expression and regulation patterns of hyaluronidases in small cell lung cancer and glioma lines. | 4.67e-10 | 3 | 28 | 3 | 12684632 | |
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 11296287 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 16600643 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 18390475 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 20849597 | ||
| Pubmed | 1.87e-09 | 4 | 28 | 3 | 17170110 | ||
| Pubmed | Hyaluronidases and CD44 undergo differential modulation during chondrogenesis. | 1.87e-09 | 4 | 28 | 3 | 11944887 | |
| Pubmed | 9.33e-09 | 6 | 28 | 3 | 11929860 | ||
| Pubmed | 1.63e-08 | 7 | 28 | 3 | 18772348 | ||
| Pubmed | The suppressive role of HYAL1 and HYAL2 in the metastasis of colorectal cancer. | 6.25e-07 | 2 | 28 | 2 | 30972813 | |
| Pubmed | Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover. | 6.25e-07 | 2 | 28 | 2 | 25468725 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 21732362 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 10339581 | ||
| Pubmed | Regulation of hyaluronidase activity by alternative mRNA splicing. | 6.25e-07 | 2 | 28 | 2 | 12084718 | |
| Pubmed | HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro. | 6.25e-07 | 2 | 28 | 2 | 18725949 | |
| Pubmed | Reactive oxygen species and hyaluronidase 2 regulate airway epithelial hyaluronan fragmentation. | 6.25e-07 | 2 | 28 | 2 | 20554532 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 11960552 | ||
| Pubmed | Lack of hyaluronidases exacerbates renal post-ischemic injury, inflammation, and fibrosis. | 6.25e-07 | 2 | 28 | 2 | 25715119 | |
| Pubmed | Respective roles of hyaluronidases 1 and 2 in endogenous hyaluronan turnover. | 6.25e-07 | 2 | 28 | 2 | 26887442 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 38490466 | ||
| Pubmed | Assignment of the human genes for desmocollin 3 (DSC3) and desmocollin 4 (DSC4) to chromosome 18q12. | 1.87e-06 | 3 | 28 | 2 | 7774948 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 23975055 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 7929347 | ||
| Pubmed | Structure and function of desmosomal proteins and their role in development and disease. | 1.87e-06 | 3 | 28 | 2 | 14523549 | |
| Pubmed | Compositionally different desmosomes in the various compartments of the human hair follicle. | 1.87e-06 | 3 | 28 | 2 | 9810708 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 17088906 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 10989127 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 9389456 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 9790770 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 8603390 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 20072653 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 23652796 | ||
| Pubmed | Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. | 3.87e-06 | 38 | 28 | 3 | 18267097 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 22438068 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 19435493 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 8486729 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 1889810 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 20875124 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 9404003 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 19140316 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 7959727 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 19577615 | ||
| Pubmed | The DNA sequence, annotation and analysis of human chromosome 3. | 1.71e-05 | 62 | 28 | 3 | 16641997 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 2.16e-05 | 67 | 28 | 3 | 21875946 | |
| Pubmed | 2.80e-05 | 10 | 28 | 2 | 12724416 | ||
| Pubmed | 4.10e-05 | 12 | 28 | 2 | 12707304 | ||
| Pubmed | Assessment of splice variant-specific functions of desmocollin 1 in the skin. | 4.85e-05 | 13 | 28 | 2 | 14673151 | |
| Pubmed | Desmosomal localization of beta-catenin in the skin of plakoglobin null-mutant mice. | 6.52e-05 | 15 | 28 | 2 | 9847250 | |
| Pubmed | Desmocollin 3 is required for pre-implantation development of the mouse embryo. | 7.45e-05 | 16 | 28 | 2 | 16418220 | |
| Pubmed | 7.45e-05 | 16 | 28 | 2 | 30689641 | ||
| Pubmed | 7.45e-05 | 16 | 28 | 2 | 29913133 | ||
| Pubmed | A genome-wide association study (GWAS) for bronchopulmonary dysplasia. | 3.45e-04 | 34 | 28 | 2 | 23897914 | |
| Pubmed | Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation. | 4.32e-04 | 38 | 28 | 2 | 29743679 | |
| Interaction | PRG2 interactions | 1.86e-05 | 285 | 24 | 5 | int:PRG2 | |
| Interaction | SDF2L1 interactions | 3.34e-05 | 322 | 24 | 5 | int:SDF2L1 | |
| Interaction | LYPD1 interactions | 4.39e-05 | 58 | 24 | 3 | int:LYPD1 | |
| Interaction | ZNF672 interactions | 8.91e-05 | 12 | 24 | 2 | int:ZNF672 | |
| Interaction | NOTCH2 interactions | 1.22e-04 | 423 | 24 | 5 | int:NOTCH2 | |
| Interaction | TMEM30B interactions | 1.37e-04 | 85 | 24 | 3 | int:TMEM30B | |
| Interaction | KRTAP3-1 interactions | 1.37e-04 | 85 | 24 | 3 | int:KRTAP3-1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 3.96e-05 | 316 | 28 | 4 | chr3p21 | |
| Cytoband | 18q12.1 | 1.16e-04 | 26 | 28 | 2 | 18q12.1 | |
| Cytoband | 10q26.3 | 4.49e-04 | 51 | 28 | 2 | 10q26.3 | |
| Cytoband | 3p21.3 | 6.01e-04 | 59 | 28 | 2 | 3p21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q12 | 1.85e-03 | 104 | 28 | 2 | chr18q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q26 | 7.08e-03 | 207 | 28 | 2 | chr10q26 | |
| GeneFamily | Desmosomal cadherins | 2.43e-05 | 7 | 20 | 2 | 1188 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 9.23e-05 | 718 | 20 | 6 | 28 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 5.30e-04 | 31 | 20 | 2 | 81 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_UP | 4.74e-05 | 197 | 27 | 4 | M9537 | |
| Coexpression | KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION | 6.78e-05 | 77 | 27 | 3 | M12971 | |
| Coexpression | NABA_ECM_REGULATORS | 9.87e-05 | 238 | 27 | 4 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 1.05e-04 | 242 | 27 | 4 | MM17062 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.85e-08 | 171 | 28 | 5 | 25493a4a7b636920e2cfd984542cc500709c9dcf | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.85e-08 | 171 | 28 | 5 | 508b41e3ad2638f9dd546d251b13ff60fc8c3207 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-06 | 169 | 28 | 4 | d6ad3b637de2935c656aad47ad82d6e8a8bd1227 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-06 | 169 | 28 | 4 | 60ef186518d0dc63dbded2a77c65cfe3129df754 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.47e-06 | 187 | 28 | 4 | 60c2576f31a60f819deb9ec500d1f714b469df4e | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.46e-06 | 195 | 28 | 4 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, condition lineage and cell class | 7.14e-06 | 200 | 28 | 4 | 511e642575182fb678df6791ee6539b0ced3eb17 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.92e-05 | 144 | 28 | 3 | 4f46a22dba047d35076e7768e834b0cbcecc8417 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.92e-05 | 144 | 28 | 3 | 3d880c140db4a0e7602bfddcb73a42a68c2848d5 | |
| ToppCell | control-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.05e-04 | 147 | 28 | 3 | 68258498202c7f580f72c46dd645071835098455 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 150 | 28 | 3 | c843bcf98c5fad2ca4339602f721f3fb782ae353 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 164 | 28 | 3 | 95ce619ebf0cf5716b099fdc71267313f9dc9d32 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 164 | 28 | 3 | d0a7e8a7c530f8d7224b50f2abe3d3642fac142b | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-NK_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-04 | 166 | 28 | 3 | b041010038a570ad929812f35514cb54e4f68f66 | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 168 | 28 | 3 | c6e0daa790dd5db20dd1ab8c1e7142484976d743 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 168 | 28 | 3 | 2c996d09b6a8ccd3c708146eca310b02eafff425 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 169 | 28 | 3 | 2c851b2703c7b8b656026f996f5fc027e4a79b36 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 170 | 28 | 3 | 71c52fadecc6b4bfe98692b266adaa1406f6d56d | |
| ToppCell | wk_15-18-Hematologic-Myeloid-GMP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.65e-04 | 171 | 28 | 3 | 4b8b67c289898ae114a07a2147b5a6f8ec9dd308 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 171 | 28 | 3 | 159ce6d5513008532dd7785b915b3fe7440cc4b2 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 172 | 28 | 3 | e680abead2da75e50774da02384eb2729c839c01 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_Tfh|normal_Lung / Location, Cell class and cell subclass | 1.71e-04 | 173 | 28 | 3 | e8ead6c51c41dbd43c717ba9d1a7a0ab39c79330 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 173 | 28 | 3 | f66aebceb3eb389bc5ff6c0b398d6f4e9959a14f | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 173 | 28 | 3 | 63f03abca84ae021ff34ff34537838aa8a1ccd11 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-04 | 173 | 28 | 3 | 94f99f7e7813d6e53e0bedf97087400b1bf00129 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 174 | 28 | 3 | ff13a5c55d18b951315908f33cb47c7f9cb901bf | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 175 | 28 | 3 | 16cf0c5d3d009480e07e8fe78c0f8555c2d6e3df | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-04 | 176 | 28 | 3 | f3bbe8c1a8d132705eac360cf531261271d84588 | |
| ToppCell | ICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, Lineage and Cell Type | 1.82e-04 | 177 | 28 | 3 | 33cd2c183ee8b597012efcbcae72131ac6beaf4e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-04 | 178 | 28 | 3 | 31c847d7f7aa0f6d820afbb45d507992f5e9dc2f | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 179 | 28 | 3 | d78eacf47847a50888dd16c35bed9b7afc80010f | |
| ToppCell | 390C-Myeloid-Dendritic-cDC1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-04 | 181 | 28 | 3 | d1c69171600b2d2aec96fa86fa757b588c265f7c | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 181 | 28 | 3 | cd81bc307e2bc42c1e9b24d5645ab65fa18c6133 | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-04 | 182 | 28 | 3 | 82d6f72649c7dd4d64a84a9795edebdef2f285d6 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 2.01e-04 | 183 | 28 | 3 | f482e4fe011fa450a475034b1e25587233855bdb | |
| ToppCell | B_cells-ABCs|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.01e-04 | 183 | 28 | 3 | bf9c6fe3ce4e44e4056027257eab8448c39c4fb8 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 2.11e-04 | 186 | 28 | 3 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-04 | 186 | 28 | 3 | 75b1f342be5d6dbe0e7acd924a0ca75964f6bab0 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-04 | 186 | 28 | 3 | 0c3d195077de7b4c354c127a26116438aef29244 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-04 | 186 | 28 | 3 | a558fd00053e7dd6216b01dc8e650c30cee451f1 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.14e-04 | 187 | 28 | 3 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 2.18e-04 | 188 | 28 | 3 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.18e-04 | 188 | 28 | 3 | db0652f000d459493321b53239326706eace598c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.21e-04 | 189 | 28 | 3 | e97c64609b1f8158d750edb869df56e5bd10538b | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 189 | 28 | 3 | 7b6cb745c0a637d6addc105a79059ed488fced39 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.25e-04 | 190 | 28 | 3 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 191 | 28 | 3 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-04 | 191 | 28 | 3 | 40e617d3c93f03ae87baf6c0b2304b617f5fe782 | |
| ToppCell | Mild-Myeloid-mDC-|Mild / Condition, Lineage, Cell class and cell subclass | 2.32e-04 | 192 | 28 | 3 | 8520b3fdf4508ac66f7918da613abc928ab5832a | |
| ToppCell | Mild-Myeloid-mDC|Mild / Condition, Lineage, Cell class and cell subclass | 2.32e-04 | 192 | 28 | 3 | da3952bd5c96242c15eb76678d0608ae2926a16e | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 192 | 28 | 3 | 35f7926628a967f85b26371e795a1b93c6f103ab | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.32e-04 | 192 | 28 | 3 | ff435141329e3e29fa9b08a4d5b2f55074e7f9ab | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 192 | 28 | 3 | f094ac378e635cf5820e8a8b7a0152073a51ceae | |
| ToppCell | droplet-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-04 | 193 | 28 | 3 | 25129080f8a40b2988a5d9dfec36ff9e72c27e61 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 193 | 28 | 3 | ffdcbc5caff7fd4cc2e83dd21a05d43b0593d542 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 2.35e-04 | 193 | 28 | 3 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | droplet-Lung-21m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-04 | 193 | 28 | 3 | 3a5ad8ffad441e30a6e1bd017da7720ad57f6c57 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 194 | 28 | 3 | f35f03412b596b6b570b377ba1a607409d984bb1 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.39e-04 | 194 | 28 | 3 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.39e-04 | 194 | 28 | 3 | b16ed97eb6b7b7a220e943474c0d85c141b6e3a5 | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.39e-04 | 194 | 28 | 3 | cf7f232827945fbafd2c298c08a799ab916c2472 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.39e-04 | 194 | 28 | 3 | 2210f0755882d8f04edb4c109fb17c3f9149f6f7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 195 | 28 | 3 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.42e-04 | 195 | 28 | 3 | 3a30479857fc2805df92655c9599389559b1995d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-04 | 195 | 28 | 3 | b0979c1b5e4576468b8fe4e9027650859e598b34 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.42e-04 | 195 | 28 | 3 | ecf7d9856a5b507ec17c325c9a772dc5a184bc8e | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 2.50e-04 | 197 | 28 | 3 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 2.50e-04 | 197 | 28 | 3 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.50e-04 | 197 | 28 | 3 | 68d8546dfe7dffd017756a11d3333061f576d0ef | |
| ToppCell | Healthy/Control-cDC|Healthy/Control / Disease group and Cell class | 2.50e-04 | 197 | 28 | 3 | 926423aae9fcf654f84b0f7621103a6a22d3aced | |
| ToppCell | Healthy_donor-cDC|World / disease group, cell group and cell class (v2) | 2.50e-04 | 197 | 28 | 3 | a545fe3a80cd721bf01115bbb645753840ec9f40 | |
| ToppCell | distal-Endothelial-Artery-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.54e-04 | 198 | 28 | 3 | f284f59f4ebe55ee132eddfaa2f5d9ecb059654f | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-04 | 199 | 28 | 3 | f4ab29f99ce45a3044d2e9f356dc24d3c5e7121f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.57e-04 | 199 | 28 | 3 | c6da5c517dbcfa621fa6dda9e0c1985ba2f3bbdb | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-04 | 199 | 28 | 3 | 5abfbccae147d399e4234f90ae5cd9529abe4dd1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.57e-04 | 199 | 28 | 3 | b9613e88c4b752529d6ae20857744418207b0830 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 28 | 3 | 1a080564de59abd59d3208a73441b6346e1c7cd8 | |
| ToppCell | Caecum-(6)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 2.61e-04 | 200 | 28 | 3 | 2ce3930645c3daf6be578f7881e57a58df61e75c | |
| ToppCell | Caecum-Macrophage|Caecum / Region, Cell class and subclass | 2.61e-04 | 200 | 28 | 3 | d83209559187a4419df2508ecc5eb9f7d72fced3 | |
| ToppCell | severe-CD163+_Monocytes_(Sample_ID1_d7)|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.61e-04 | 200 | 28 | 3 | 4943fe826d5fcc3dfeb8b99a7415848f3fecc994 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.61e-04 | 200 | 28 | 3 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 28 | 3 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | (53)_Lymphoid_DC|World / shred on Cell_type and subtype | 2.93e-04 | 208 | 28 | 3 | 30212cfacad94a7cc562a69efa73a31259851515 | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.76e-06 | 196 | 28 | 5 | 3971_DN | |
| Drug | Piperidino acetanilide | 3.05e-05 | 7 | 28 | 2 | CID000078402 | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 8.91e-05 | 194 | 28 | 4 | 4134_DN | |
| Drug | Cefaclor [70356-03-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 8.91e-05 | 194 | 28 | 4 | 4967_UP | |
| Drug | Phenacetin [62-44-2]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 8.91e-05 | 194 | 28 | 4 | 4111_DN | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 9.09e-05 | 195 | 28 | 4 | 4991_UP | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 4689_DN | |
| Drug | F0447-0125; Up 200; 10uM; PC3; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 6401_UP | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 2558_DN | |
| Drug | Tobramycin [32986-56-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 4081_DN | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 2768_UP | |
| Drug | Reserpine [50-55-5]; Down 200; 6.6uM; HL60; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 3003_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 3748_UP | |
| Drug | Butirosin disulfate salt [51022-98-1]; Up 200; 5.4uM; HL60; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 2518_UP | |
| Drug | Aminophylline [317-34-0]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.00e-04 | 200 | 28 | 4 | 3036_DN | |
| Disease | desmocollin-2 measurement | 7.45e-06 | 5 | 26 | 2 | EFO_0021936 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (implicated_via_orthology) | 7.45e-06 | 5 | 26 | 2 | DOID:0050431 (implicated_via_orthology) | |
| Disease | Keloid | 1.01e-04 | 17 | 26 | 2 | EFO_0004212 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 5.42e-04 | 39 | 26 | 2 | EFO_0008298 | |
| Disease | bronchopulmonary dysplasia | 7.22e-04 | 45 | 26 | 2 | MONDO_0019091 | |
| Disease | Thyroid preparation use measurement | 9.00e-04 | 217 | 26 | 3 | EFO_0009933 | |
| Disease | hypothyroidism | 1.95e-03 | 284 | 26 | 3 | EFO_0004705 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 2.26e-03 | 80 | 26 | 2 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Eczema | 2.50e-03 | 310 | 26 | 3 | HP_0000964 | |
| Disease | orofacial cleft, sex interaction measurement | 2.61e-03 | 86 | 26 | 2 | EFO_0008343, MONDO_0000358 | |
| Disease | neuritic plaque measurement | 3.49e-03 | 349 | 26 | 3 | EFO_0006798 | |
| Disease | eosinophil measurement | 4.07e-03 | 108 | 26 | 2 | EFO_0803540 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DVSACLRRRSHGDRC | 116 | P0C7V0 | |
| ARGERRGCSRACEHH | 1006 | Q8IWY9 | |
| SCRGAGHHHTLDSCR | 796 | Q02487 | |
| RAGGHCCARALRAHN | 156 | Q9UPQ7 | |
| RHGPRRCHSNCRGDS | 66 | Q7Z2G1 | |
| EHACRSDGRRARVTC | 141 | P30203 | |
| SRAQCHGHGRCVRRN | 366 | Q12891 | |
| HSSCRTCEGRHSRQC | 1521 | Q92824 | |
| RGRRRHCCSSAEAET | 91 | O95263 | |
| RYGTRCSRCGRHIHS | 131 | Q68G74 | |
| RGRTCRGRKFDGHRC | 346 | P27918 | |
| CHLRTRTDRCRRGFG | 26 | B3GLJ2 | |
| CTRGGHWRRAHCLRR | 201 | P13727 | |
| CDAHHRGRSRACTGR | 141 | Q96QU4 | |
| SCRGAGHHHTLDSCR | 791 | Q14574 | |
| CSHQRCHGHGRCARR | 356 | O43820 | |
| FNALTRRRHHCRACG | 471 | Q7Z6J4 | |
| ALCSGHGRCVRRTSH | 361 | Q12794 | |
| ELVHRNGSHARCRCS | 2501 | Q9NYQ7 | |
| FCSSLHSAHRGRDCR | 81 | Q6PJ21 | |
| QAPGRAHRCAHCRRH | 51 | Q9BWE0 | |
| VCRRLEASGHERGCH | 26 | A0A1B0GUT2 | |
| AHSTGERRHRCNECG | 231 | Q96LW9 | |
| HRCAVCGRRFGHRSN | 231 | Q7L3S4 | |
| RFSLTERRHHCRNCG | 3466 | Q8IZQ1 | |
| RHERAHGGDGRFRCL | 31 | Q499Z4 | |
| RHFSTSRGGHHCARR | 21 | Q5XG85 | |
| SHTGQRRHFCSDCGR | 416 | Q9NWS9 | |
| IRHGSRRHGVCTDCA | 491 | Q86UZ6 |